"Medskan issues its initial bond of 3 billion rubles"
In a significant move towards implementing its strategic plans, the healthcare company GK "Medscan" has successfully issued bonds, attracting high interest from investors. The credit rating agency Expert RA has assigned a credit rating of "ruA" to these bonds, indicating a moderate credit risk.
The debut bond issue allowed GK "Medscan" to reduce the coupon rate by 150 basis points from the initial target, offering an attractive monthly coupon rate of 1.541667% per month (18.5% per annum) to investors. This reduction in the coupon rate is a testament to the strong investor confidence in GK "Medscan" and the healthcare market as a whole.
Ilya Nikolaev, Director of Economics and Finance at GK "Medscan", expressed his delight at the high interest from investors, stating, "The high interest from investors confirms confidence in the healthcare market and interest in GK 'Medscan'."
The order book for the bonds closed on July 1, with the main investors coming from private banks, trust management and brokerage platforms, as well as insurance, management, and investment companies. This diversified investor base will help GK "Medscan" build stable relationships with the professional investment community.
The issuance period for the bonds is 2.2 years, and they are included in the second level of the listing. This move into the public market will further enhance GK "Medscan's" visibility and credibility in the financial market.
While a comprehensive analysis of the performance of these bonds requires detailed financial data and market information, the successful issuance and high investor interest suggest a positive outlook for GK "Medscan" and the healthcare sector. For those seeking a current analysis or forecast, financial news platforms and bond market data providers may offer more specific insights.
The successful bond issuance by GK "Medscan" has resulted in a reduction of the coupon rate by 150 basis points, indicating a significant decrease in the company's financing costs. Ilya Nikolaev, the Director of Economics and Finance at GK "Medscan," attributes this to strong investor confidence in the healthcare market and the company itself.
